p53 has been known to regulate tumour cells glucose metabolism by suppressing the expression of GLUT3, as well as TP53‐induced glycolysis and apoptosis regulator (TIGAR) and hexokinase 2 (HK2), which plays important roles in glycolysis.71, 72. The gene discussed is SLC2A3; the disease is neoplasm.